Klinische Wochenschrift

, Volume 63, Issue 14, pp 631–635 | Cite as

DNS-Gehalt von Lymphocyten und einkernigen Tumorzellen beim Morbus Hodgkin

  • K. Donhuijsen
  • H. Grethe
  • L-D Leder
Originalien
  • 10 Downloads

Abkürzungsverzeichnis

c

content

2c

diploid

DNS

Desoxyribonukleinsäure

l.d.

lymphocytenarmer Typ

m.c.

mischzelliger Typ

n.s.

nodulär sklerosierender Typ

s

Standardabweichung

DNA content of lymphocytes and malignant mononuclear cells in Hodgkin's disease

Summary

Thirteen lymph node biopsy specimens with Hodgkin's disease (six cases of the nodular sclerosis type; six cases of the mixed cellularity type; one case of the lympocytic depletion type) were studied with scanning cytophotometric measurements. The DNA content of small lymphocytes, large lymphocytes, atypical mononuclear cells and Hodgkin cells was measured. The sizes of the nuclei and mitotic indices were also measured. There were no lymphocytes with aneuploid DNA stemlines. Large lymphocytes showed proliferative activity which is possibly reactive, although its neoplastic character cannot be excluded. Hodgkin cells exhibited aneuploid values in seven cases and atypical mononuclear cells in only four cases. The nuclear sizes and the DNA content of the atypical mononuclear cells ranged between the values of lymphocytes and Hodgkin cells. The mixed cellularity type showed higher DNA values, more frequently occurrence of aneuploid stemlines and a higher frequency of mitotic figures than did the nodular sclerosis type. The results confirm the different grades of malignancy of the various histopathological categories of Hodgkin's disease.

Key words

Hodgkin's disease DNA Cytometry Mitoses Grading 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Barlogie B, Latreille J, Freireich EJ, Fu Chi-Tse, Mellard D, Meistrich M, Andreeff M (1980) Characterization of hematologic malignancies by flow cytometry. Blood Cells 6:719–744Google Scholar
  2. 2.
    Coltman CA Jr, Dixon DO (1982) Second malignancies complicating Hodgkin's disease: A southwest oncology group 10-year followup. Cancer Treat Rep 66:1023–1033Google Scholar
  3. 3.
    DeVita VT Jr, Hellmann S (1982) Hodgkin's disease and the Non-Hodgkin's lymphomas. In: DeVita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer. Principles and practice of oncology JB Lippincott, Philadelphia Toronto, p 1331–1401Google Scholar
  4. 4.
    Diamond LW, Nathwani BN, Rappaport H (1982) Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 50:1122–1135Google Scholar
  5. 5.
    Diehl V, Peters HD, Rühl U, Brücher H, v Roemeling R, Günther B (1983) Prospektive Therapiestudie zum Morbus Hodgkin, Therapieprotokolle HD1, HD2, HD3. Verh Dtsch Krebs-Ges 4:743–753Google Scholar
  6. 6.
    Donhujisen K (1982) Untersuchungen von Mitosefrequenz, Kerngrößen und Zellkern-DNS-Gehalt an Non-Hodgkin-Lymphomen: Ein Beitrag zur Problematik der Lymphom-Klassifikationen. (Habilitationsschrift Essen)Google Scholar
  7. 7.
    Donhujisen K, Winkelmeyer M, Hirche H, Leder LD (1983) Über Pseudofollikel bei der chronischen lymphatischen Leukämie. Zbl allg Pathol pathol Anat 127:109–118Google Scholar
  8. 8.
    Jackson H (1937) The classification and prognosis of Hodgkin's disease and allied disorders. Surg Gynecol Obstet 64:465–467Google Scholar
  9. 9.
    Keller AR, Kaplan HS, Lukes RJ, Rappaport H (1968) Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer 22:487–499Google Scholar
  10. 10.
    Lawler SD (1973) Cytogenetic studies. In: Smithers D (ed) Hodgkin's disease. Churchill Livingstone, Edinburgh London New York, p 55–63Google Scholar
  11. 11.
    Leder LD (1976) Morphologische Aspekte des Morbus Hodgkin. Therapiewoche 26:8806–8811Google Scholar
  12. 12.
    Peckham MJ, Cooper EH (1969) Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer 24:135–146Google Scholar
  13. 13.
    Rappaport H (1966) Tumors of the Hematopoietic system. Atlas of tumor pathology Sec III Fasc. 8. AFIP, Washington DCGoogle Scholar
  14. 14.
    Rowley JD (1982) Chromosomes in Hodgkin's disease. Cancer Treat Rep 66:639–643Google Scholar
  15. 15.
    Sachs L (1984) Angewandte Statistik. Springer, Berlin Heidelberg New York Tokyo, p 230–240Google Scholar
  16. 16.
    Sandberg AA (1980) The chromosomes in human cancer and leukemia. Elsevier, New York Amsterdam, p 378–412Google Scholar
  17. 17.
    Sandritter W (1981) The Maude Abbott lecture. Path Res Pract 171:2–21Google Scholar
  18. 18.
    Schwarze EW, Gödde-Salz E, Lennert K (1982) Zytogenetische Befunde bei Morbus Hodgkin, Lymphogranulomatosis X und T-Zonen-Lymphom. Verh Dtsch Ges Path 66:127–133Google Scholar
  19. 19.
    Shackney SE, Skramstad KS, Cunningham RE, Dugas DJ, Lincoln TL, Lukes RJ (1980) Dual parameter flow cytometry studies in human lymphomas. J Clin Invest 66:1281–1294Google Scholar

Copyright information

© Springer-Verlag GmbH & Co. KG 1985

Authors and Affiliations

  • K. Donhuijsen
    • 1
  • H. Grethe
    • 1
  • L-D Leder
    • 1
  1. 1.Westdeutsches TumorzentrumInstitut für Pathologie der Universitätsklinik EssenGermany

Personalised recommendations